WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
0.12
%
1,64%
Latest
7.42
High
7.48
Low
7.16
Volume
27 361
Turnover (SEK)
198 870
Value (MSEK)
188,3

Board

CEO

  • Peter Morsing

Chairman Of The Board

  • Gudrun Anstrén

Board

  • Jan Nilsson
  • Martin Olovsson
  • Peter Ström
  • Sten Trolle
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 12,84 12,84 2019-06-30
Nordnet Pensionsförsäkring 10,31 10,31 2019-06-30
Kjell Stenberg 5,97 5,97 2019-06-30
Tommy Andersson 4,24 4,24 2019-06-30
Lars-Erik Forsgårdh 2,14 2,14 2019-06-30
Leif Bertils 1,13 1,13 2019-06-30
Nils Qvarner 1,10 1,10 2019-06-30
Bostadsrättsbyggarna Svenska Holding AB 0,92 0,92 2019-06-30
Swedbank Försäkring 0,70 0,70 2019-06-30
Livförsäkringsbolaget Skandia 0,68 0,68 2019-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Inquiry Financial

Upcoming reports

  • 2019-08-15 Delårsrapport 2019-Q2

  • 2019-11-14 Delårsrapport 2019-Q3

  • 2020-02-20 Bokslutskommuniké 2019